74 results on '"Zhou, Shuntai"'
Search Results
2. The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus
3. Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants
4. High Genetic Diversity of HIV-1 and Active Transmission Clusters among Male-to-Male Sexual Contacts (MMSCs) in Zhuhai, China
5. N4-Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
6. Use of Next-Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-COV-2 Pandemic on HIV-1 Diagnosis and Transmission
7. Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
8. Author response: Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
9. Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus
10. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
11. 2073. Persistent HIV-1 Viremia Despite Intensive Antiviral Therapy Due to Non-responsive Clonal Viral Lineages
12. 796. HIV transmission clusters among people who inject drugs in North Carolina, 2010 to 2021
13. Unique Molecular Identifiers and Multiplexing Amplicons Maximize the Utility of Deep Sequencing To Critically Assess Population Diversity in RNA Viruses
14. Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation
15. A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors
16. Sequencing the Biology of Entry: The Retroviral env Gene
17. COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors
18. HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria
19. Reply to Troth et al
20. β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
21. Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome
22. The HIV-1 latent reservoir is largely sensitive to circulating T cells
23. Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in Mice
24. Author response: The HIV-1 latent reservoir is largely sensitive to circulating T cells
25. Fact and Fiction about 1%: Next Generation Sequencing and the Detection of Minor Drug Resistant Variants in HIV-1 Populations with and without Unique Molecular Identifiers
26. Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID–Next-Generation Sequencing in North Carolina
27. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
28. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi
29. Deep Sequencing Reveals Compartmentalized HIV-1 in the Semen of Men with and without Sexually Transmitted Infection-Associated Urethritis
30. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
31. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus
32. Deep Sequencing Reveals Compartmentalized HIV-1 in the Semen of Men with and without STI-associated Urethritis
33. DETECTING SOLAR ULTRAVIOLET IMPACT ON STRATOSPHERIC OZONE
34. Observation, Theory and Modeling of Atmospheric Variability
35. Selection of HIV-1 for Resistance to Fifth Generation Protease Inhibitors Reveals Two Independent Pathways to High-Level Resistance
36. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation
37. Primer ID MiSeq Library Prep for HIV-1 DR and diversity v1
38. Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance
39. Quantifying Virus Escape from T Cells in the Latent HIV Reservoir
40. The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation
41. Primer ID MiSeq Library Prep v4
42. Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use
43. Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus
44. Primer ID MiSeq Library Prep v3
45. Using Primer-ID Deep Sequencing to Detect Recent Human Immunodeficiency Virus Type 1 Infection
46. Primer ID MiSeq Library Prep v2
47. Primer ID MiSeq Library Prep v1
48. Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1–Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing
49. Characterizing HIV-1 Splicing by Using Next-Generation Sequencing
50. Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.